# Abbott Laboratories (ABT) — Q3-2017 Earnings Results

**Report date:** 2017-10-18 (before market open)  
**Sector:** Health Care / Health Care Equipment  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/ABT/earnings/Q3-2017

## Post-Earnings Brief

### Headline

Abbott Laboratories Beats on EPS, Stock Up 1.29%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.66 | N/A | +0.39% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Unknown

No transcript is on record for the earnings call, so the analysis is based solely on the numerical results.

### Guidance Changes

No guidance data is available for this quarter.

### What It Means

Abbott Laboratories reported earnings that exceeded expectations on EPS, which contributed to a positive stock reaction, with shares rising by 1.29%. However, there was no revenue data or guidance provided, leaving some uncertainty about the company's future performance. Investors may be encouraged by the EPS beat but will likely look for more information in future reports.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/ABT/earnings/Q3-2017_